Cargando…
PSMB5对多发性骨髓瘤细胞增殖和硼替佐米耐药的影响及其机制研究
OBJECTIVE: To investigate the effects of proteasome beta 5 subunit (PSMB5) on proliferation and bortezomib (BTZ) chemo-sensitivity of multiple myeloma (MM) and its related molecular mechanisms. METHODS: We used two MM cell lines, RPMI 8226 and BTZ drug-resistant cell line RPMI 8226/BTZ100 (hereinaft...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342182/ https://www.ncbi.nlm.nih.gov/pubmed/29365400 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2017.12.010 |
Ejemplares similares
-
Cdc37 调控细胞自噬参与骨髓瘤细胞对硼替佐米耐药的研究
Publicado: (2020) -
BDDT方案对硼替佐米治疗原发耐药或疗效不佳的多发性骨髓瘤患者的临床疗效分析
Publicado: (2015) -
CMTM5表达对多发性骨髓瘤细胞增殖的影响及其机制研究
Publicado: (2019) -
1q21扩增对硼替佐米治疗初治多发性骨髓瘤患者疗效和预后的影响
Publicado: (2018) -
小檗碱联合硼替佐米对多发性骨髓瘤细胞株U266细胞作用机制的体外研究
Publicado: (2016)